27 |
ABL PROTO-ONCOGENE 2, NON-RECEPTOR TYROSINE KINASE |
ABL2 |
ABLL |
ARG |
164690 |
77 |
ENSG00000143322 |
OTTHUMG00000035199 |
P42684 |
ABELSON TYROSINE-PROTEIN KINASE 2 |
ABL2_HUMAN |
Q5W0C5_HUMAN |
101 |
Tyrosine-protein kinase ABL2 |
Initial Gene Query | ARG/abl2 |
Counted Citations from 1950-2000 | 2609 |
Human Readable Name | KINASE |
Human Readable Name | DRUGGABLE GENOME |
Interpro Short Name | Ser-Thr/Tyr_kinase_cat_dom |
Uniprot Evidence | 1: Evidence at protein level |
Interpro Acc | IPR001245 |
Interpro Type | Domain |
Interpro Name | Serine-threonine/tyrosine-protein kinase catalytic domain |
Uniprot Status | Swiss-Prot |
Target Class | Enzymes |
Target Subclass | EC:2.7.10.2 |
Target Main Class | Enzymes |
Target Subclass | 2.7.10.2 |
Gene Biotype | PROTEIN_CODING |
KINASE |
TYROSINE KINASE |
DRUGGABLE GENOME |
CLINICALLY ACTIONABLE |
ABL2 | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
27 | Entrez Gene ID |
Initial Gene Query | ARG/abl2 |
Counted Citations from 1950-2000 | 2609 |
KINASE |
27 | Entrez Gene Id |
P42684 | Uniprot Accession |
ENSG00000143322 | Ensembl Gene Id |
Target Main Class | Enzymes |
Target Subclass | 2.7.10.2 |
ABL2 | Uniprot Gene Name |
P42684 | Uniprot Accession |
27 | Entrez Gene Id |
Human Readable Name | KINASE |
Human Readable Name | DRUGGABLE GENOME |
Interpro Short Name | Ser-Thr/Tyr_kinase_cat_dom |
KINASE, DRUGGABLE GENOME |
ENSG00000143322 | Ensembl Gene Id |
Q5W0C5_HUMAN | Display Id |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
ABL2 | Gene Symbol |
Target Class | Enzymes |
Target Subclass | EC:2.7.10.2 |
27 | Entrez Gene ID |
101 | CIViC Gene ID |
ENSG00000143322 | Gene Symbol |
ABL2 | Ensembl Id |
DRUGGABLE GENOME |
ABLL | GO Gene Synonym |
ARG | GO Gene Synonym |
TYROSINE KINASE |
ABL2 | Gene Symbol |
CLINICALLY ACTIONABLE |
27 | Gene ID |
ABLL | dGene Synonym |
ARG | dGene Synonym |
KINASE, TYROSINE KINASE |
Tyrosine-protein kinase ABL2 | Gene Name |
P42684 | UniProt ID |
KINASE |
CLINICALLY ACTIONABLE |
CLINICALLY ACTIONABLE |